Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 10/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.38 |
| ▸ | HASPIN | Q8TF76 | 4/20 | 0.38 |
| ▸ | MAP3K12 | Q12852 | 1/20 | 0.38 |
| ▸ | KIT | P10721 | 1/20 | 0.38 |
| ▸ | PIM1 | P11309 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 1/20 | 0.38 |
| ▸ | CDK7 | P50613 | 1/20 | 0.38 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.38 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.38 |
| ▸ | SMO | Q99835 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL625732 | 0.95 | PIK3CA (0.53) | PIK3CAKCNH2MAP3K12 | |
| SCHEMBL624869 | 0.90 | PIK3CA (0.52) | PIK3CAKCNH2HASPINMAP3K12 | |
| SCHEMBL626168 | 0.87 | PIK3CA (0.53) | PIK3CAKCNH2HASPINMAP3K12KIT | |
| SCHEMBL624968 | 0.86 | MAP3K12 (0.43) | PIK3CAMAP3K12SMO | |
| SCHEMBL627410 | 0.84 | PIK3CA (0.57) | PIK3CAKCNH2HASPINKITPIM1 | |
| SCHEMBL625620 | 0.83 | PIK3CA (0.56) | PIK3CAKCNH2HASPINKITPIM1 | |
| SCHEMBL625746 | 0.83 | PIK3CA (0.54) | PIK3CAKCNH2HASPINKITPIM1 | |
| SCHEMBL625131 | 0.83 | PIK3CA (0.49) | PIK3CAKCNH2HASPINKITPIM1 | |
| SCHEMBL627372 | 0.83 | PIK3CA (0.57) | PIK3CAKCNH2HASPINMAP3K12KIT | |
| SCHEMBL626463 | 0.83 | PIK3CA (0.53) | PIK3CAKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |